Cargando…
Polyphenols as alternative treatments of COVID-19
Although scientists around the world have put lots of effort into the development of new treatments for COVID-19 since the outbreak, no drugs except Veklury (remdesivir) have been approved by FDA. There is an urgent need to discover some alternative antiviral treatment for COVID-19. Because polyphen...
Autores principales: | Wu, Yifei, Pegan, Scott D., Crich, David, Desrochers, Ellison, Starling, Edward B., Hansen, Madelyn C., Booth, Carson, Nicole Mullininx, Lauren, Lou, Lei, Chang, Kuan Y., Xie, Zhong-Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452152/ https://www.ncbi.nlm.nih.gov/pubmed/34567475 http://dx.doi.org/10.1016/j.csbj.2021.09.022 |
Ejemplares similares
-
Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp)
por: Wu, Yifei, et al.
Publicado: (2021) -
Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening
por: Wu, Yifei, et al.
Publicado: (2023) -
A Pilot Study of All-Computational Drug Design Protocol–From Structure Prediction to Interaction Analysis
por: Wu, Yifei, et al.
Publicado: (2020) -
In silico identification of drug candidates against COVID-19
por: Wu, Yifei, et al.
Publicado: (2020) -
Encapsulating Cas9 into extracellular vesicles by protein myristoylation
por: Whitley, Joseph Andrew, et al.
Publicado: (2022)